January 7, 2020
genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system Lyon, France - genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic alliance with Merck, a leading science and technology company and leader in genome editing. In December 2018, genOway [...]
TwinStrand Biosciences Accelerates Commercialization with $16M in Series A Funding
January 7, 2020
SEATTLE -- TwinStrand Biosciences™, a novel genetic sequencing technology company, today announced the close of $16 million in Series A funding, including $12 million in new capital. Madrona Venture Group led the investment with participation from Alexandria Venture Investments, Ridgeback Capital and Sahsen Ventures. The funding will be used to accelerate the company's commercial pipeline, as well as to [...]
ArcherDX Appoints Mark Massaro Chief Financial Officer
January 7, 2020
BOULDER, Colo.— ArcherDX, Inc., a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized genomic medicine, today announced Mark Massaro has been appointed Chief Financial Officer. Mark Massaro, ArcherDX Chief Financial Officer “We are thrilled to welcome Mark to the ArcherDX team,” said Jason Myers, Chief Executive Officer. “Mark’s extensive [...]
TRILINK BIOTECHNOLOGIES EXPANDS IP PORTFOLIO WITH TWO NEW PATEN
January 7, 2020
Advancements Expected to Accelerate Development of mRNA Therapeutics SAN DIEGO – TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids such as DNA and RNA, announced today that the United States Patent and Trademark Office has issued two new patents to the company. Both patents cover advancements in TriLink’s [...]
Paul Netzsch to expand the Executive Board of the NETZSCH Group
January 7, 2020
Selb – Paul Netzsch will be appointed Member of the Executive Board of Erich NETZSCH GmbH & Co. Holding KG as of 1 April 2020. With the 33-year-old business economist, one more member of the shareholder family will head the NETZSCH Group. In the future, Paul Netzsch along with Moritz Netzsch and Jens Niessner with [...]
MGI Receives Regulatory Clearance of its G and T Series Sequencers in APAC Countries and Europe
January 7, 2020
MGI announced today that it has the market clearance for its G and T Series sequencers in Asia Pacific countries and Europe. Its DNBSEQ-T7, DNBSEQ-G400 and DNBSEQ-G50 sequencers are now cleared in European countries recognizing the CE-IVD mark and ready to position in clinical settings. The European IVD CE Mark approval opens up a wider global market [...]
BIO-TECHNE REBRANDS ATLANTA BIOLOGICALS SERUM AND MEDIA AS PART OF THE R&D SYSTEMS PRODUCT PORTFOLIO
January 7, 2020
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced that the Atlanta Biologicals portfolio of serum and media will be rebranded as R&D Systems. As part of the rebranding, the Atlanta Biologicals website will be retired and the entire serum and media portfolio, including product details and purchasing options, will be maintained through the R&D Systems [...]
Asahi Glassplant UK acquires Syrris and Glass Solutions to increase portfolio for chemistry market
January 7, 2020
Asahi Glassplant UK Ltd. (AG! UK) is excited to announce the successful acquisition of the Syrris and Glass Solutions businesses from Blacktrace Holdings Ltd. (Blacktrace), Royston, UK, on 1st January 2020. AG! UK, a subsidiary of Asahi Glassplant Inc., Japan, is a world-leading innovator in glass technology for scientific applications. The AG! group has a focus on expanding its global presence and has strategically set up AG! UK to [...]
Acquisition of JEOL KOREA LTD.
January 6, 2020
JEOL Ltd. (headquartered in Akishima, Tokyo; JEOL hereafter) and DI Corporation (headquartered in Gangnam-gu, Seoul, Korea; DI hereafter) entered into an agreement for JEOL to acquire all of DI-owned shares of JEOL KOREA LTD. (headquartered in Gangdong-gu, Seoul, Korea; JK hereafter) and make JK a wholly-owned subsidiary of JEOL. Background and Objective In overseas operations, [...]
January 6, 2020
Leading local firm driving adoption of biotechnology for yield, safety, and consistency throughout the region BEVERLY, Mass. -- Medicinal Genomics Corp. (MGC), a pioneer in genomics and blockchain technology to improve the yield, safety, and transparency of cannabis, today announced its partnership with Analogic Solutions as its distributor of record for the Caribbean region. Analogic is headquartered in Trinidad and [...]

